GlassScriptPhysician profile
Marc A Kaufman
NPI 1548299415
$3,138.19
in general payments reported to CMS, 2019-2025
31 companies · $566 in 2025
The $566 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $84.93 · 2021: $69.19 · 2022: $579 · 2023: $679 · 2024: $747 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,938 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,938.21 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $408.86 | 2019-2025 | Evenity, Prolia, Prolia |
| Astellas Pharma US INC | $386.58 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $287.71 | 2022-2024 | |
| Shield Therapeutics INC | $285.41 | 2023-2025 | Accrufer |
| Abbvie INC. | $253.00 | 2019-2024 | |
| Gynesonics, INC. | $213.73 | 2022 | |
| Exeltis, USA INC. | $160.51 | 2019-2024 | Slynd |
| Coopersurgical, INC. | $153.30 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $128.60 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $113.10 | 2023-2025 | Myfembree |
| Exact Sciences Corporation | $99.81 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $95.64 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Biogen, INC. | $70.69 | 2025 | Zurzuvae |
| Pfizer INC. | $67.46 | 2019-2024 | |
| Therapeuticsmd, INC. | $56.13 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $53.40 | 2024 | |
| Mallinckrodt Enterprises LLC | $40.25 | 2019 | |
| Meditrina | $33.57 | 2021 | |
| Myovant Sciences INC. | $24.13 | 2022 | |
| Optumhealth Care Solutions, LLC | $21.69 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Scynexis, INC. | $21.18 | 2022 | |
| Merck Sharp & Dohme LLC | $20.52 | 2023 | Gardasil 9 |
| Organon LLC | $20.49 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $19.08 | 2024 | Exparel |
| Amag Pharmaceuticals, INC. | $16.63 | 2019 | |
| Smith+Nephew, INC. | $15.91 | 2024 | Pico 14, Pico |
| Ethicon US, LLC | $15.54 | 2025 | Dermabond Prineo, Ethicon, Vistaseal |
| Daiichi Sankyo INC. | $14.82 | 2024 | Injectafer |
| Vertical Pharmaceuticals, LLC | $14.23 | 2019 | |
| Teleflex LLC | $13.37 | 2019 | |
| Avion Pharmaceuticals | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.